ENTA
Enanta Pharmaceuticals Inc
12.20$
-2.6%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
Enanta Pharmaceuticals Inc (ENTA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -19 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20 | 77 | 36 | 53 | 29 | 71 | 7.1 | -70 | -85 | -103 | -79 | -19 | |
| 0.4 | 0.6 | 1.7 | 2.1 | 2.5 | 3.3 | 3.6 | 3.3 | 3.0 | 2.4 | 2.3 | 5.1 | |
| 2.7 | 5.8 | 9.4 | 13 | 16 | 19 | 20 | 21 | 27 | 28 | 27 | 19 | |
| -14 | 14 | 4.8 | 10 | 17 | 10 | 26 | 19 | 27 | – | – | – | |
| -2.3 | -17 | 6.2 | 22 | -62 | 11 | 13 | -14 | 6.8 | 8.0 | 7.1 | 40 | |
| 1.0 | 2.3 | 4.7 | 2.5 | 3.0 | 5.4 | 1.4 | 0.8 | 2.1 | 9.1 | 18 | 13 | |
| 0.5 | -88 | -44 | -4.6 | -35 | -87 | 20 | 37 | 55 | -54 | 58 | 40 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.7 | – | – | – | – | – | – | |
| 1.1 | 2.5 | 1.0 | -0.2 | -1.8 | -4.2 | -1.5 | -0.5 | -1.2 | -3.8 | – | – | |
| -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | – | – | 0.0 | 0.0 | -27 | – | |
| 1.2 | 2.5 | 2.7 | 1.0 | 4.4 | 2.6 | 9.0 | 3.1 | 20 | 198 | -28 | -27 | |
| 22 | -9.0 | -5.1 | 49 | -1.8 | -13 | 36 | -30 | -9.9 | 41 | -48 | -5.5 | |
| 19 | 74 | 31 | 50 | 26 | 66 | 5.6 | -71 | -87 | -112 | -97 | -32 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.